Hepatitis screening now for all patients with cancer on therapyAugust 6, 2020Mantle Cell LymphomaB Cell Lymphoma
Experts break down latest CAR T-cell advances in lymphomaJanuary 22, 2020B Cell LymphomaMantle Cell Lymphoma
LOXO-305: Next-gen BTK inhibitor safe and effective in B-cell malignanciesDecember 20, 2019Mantle Cell LymphomaB Cell LymphomaCLL
Some MCL patients can safely stop venetoclax-ibrutinib, study suggestsDecember 14, 2019Mantle Cell LymphomaB Cell Lymphoma
KTE-X19 produces highest response rate in MCL subgroupDecember 14, 2019Mantle Cell LymphomaB Cell Lymphoma
Orelabrutinib could be ‘preferred’ BTK inhibitor for MCLDecember 12, 2019Mantle Cell LymphomaB Cell Lymphoma
Acalabrutinib may outperform other targeted therapies in MCLDecember 4, 2019Mantle Cell LymphomaB Cell Lymphoma
FDA approves Brukinsa for relapsed, refractory MCLNovember 15, 2019Mantle Cell LymphomaB Cell Lymphoma
Survival ‘excellent’ after rituximab-bendamustine induction in transplant-eligible MCLNovember 6, 2019Mantle Cell Lymphoma
Follow-up shows favorable results with acalabrutinib in MCLOctober 8, 2019Mantle Cell LymphomaB Cell Lymphoma
